Pfizer looks to consolidate in Cambridge; Nuron licenses Alzheimer's vaccine; Raptor tries for early regulatory win;

@FierceBiotech: Wellcome Trust joins chorus calling for free online access to medical research. Story | Follow @FierceBiotech

@JohnCFierce: Affymax collects a $50M milestone check for peginesatide approval. Release | Follow @JohnCFierce

@RyanMFierce: GAVI scores price cuts for $GSK and $MRK rotavirus shots. News | Follow @RyanMFierce

> Pfizer ($PFE) has put Wyeth's old HQ building in Cambridge, MA, up for sale, hoping it can relocate the workers there to its facilities in Kendall Square. Story

> Nuron Biotech has licensed an experimental Alzheimer's vaccine from Vitruvian. Financial details were not disclosed. Report

> Just 6 years after it was founded, Raptor Pharmaceutical ($RPTP) is hoping it can gain its first drug approval. Story

Pharma News

@FiercePharma: Teva's newly confirmed hold on the Provigil market makes its forecast look 'conservative,' analyst tells Bloomberg. More | Follow @FiercePharma

> Predictably, Icahn sues Amylin to open proxy fight. News

> J&J looks for workaround to ease Doxil shortage. Item

Medical Devices News

@FierceMedDev: FDA combats criticisms over speed with ESRD pathway. Story | Follow @FierceMedDev

> Medtronic backs Hauser's findings on Riata leads. More

> Medtronic starts Jacksonville, FL, expansion. Item

Research News

> Tarantula venom, baking soda explored to fight breast cancer. Item

> Salk scientists eye 2 new targets against Type 2 diabetes. More

> Novel drug blasts leukemia in zebra fish. Piece

> Three studies back notion of autism erupting from genetic mutations. Article

> Novartis drug discovery repairs arthritic knees in mice. Story

Manufacturing News

> FDA builds program for outsourcing foreign plant inspections. Item

> New plant pushes Ranbaxy Lipitor production to global lead. Article

> FDA disbars 4 quality control execs from defunct Able Laboratories. More

> India considers track and trace system to combat counterfeiters. News

And Finally… A new study suggests those omega-3 supplements don't do anything to improve cardiovascular health. Story